Alexander Burik, Author at Labiotech.eu

The crucial role of rapid toxicology material delivery

Accelerating the path to clinical filing applications with rapid toxicology material delivery

Pre-clinical toxicology studies and prompt material delivery are essential for IND and CTA approvals, crucial for advancing drug candidates to clinical trials.

September 10, 2024 - 8 minutesmins - By Alexander Burik

The crucial role of GS-CHO innovation in biopharmaceutical progress

Learn how GS-CHO systems are advancing to improve yields and quality in biomanufacturing, meeting the rising need for effective therapeutic proteins.

September 3, 2024 - 8 minutesmins - By Alexander Burik

large molecule manufacturing: Lonza woman working in laboratory

Large molecule manufacturing: addressing challenges with strategies for success

Discover the landscape of large molecule manufacturing, exploring challenges, latest innovations, and winning strategies for success.

March 26, 2024 - 8 minutesmins - By Alexander Burik

Sustainable drug discovery and development: how a CDMO can help you

More sustainable drug development and lab sustainability

From reducing carbon footprints to optimising costs, explore innovative solutions for sustainable drug discovery and development!

February 20, 2024 - 6 minutesmins - By Alexander Burik

ODS Paris In vitro 386 Antoine Martel Photographe

Chronic inflammation and cancer: how can preclinical models revolutionize our understanding?

In most cases, chronic inflammation is known to lead to cancer, however, the mechanisms behind this are not fully understood. Preclinical models in immuno-oncology are the first step towards a better understanding of cancer mechanisms, improved treatments and prevention of cancer caused by inflammation. Inflammation is the immune system’s natural response to bacterial, viral, and […]

October 24, 2023 - 7 minutesmins - By Alexander Burik

Reports by 16 May 2023

Report: Outsourcing in Life Science R&D Today

Over the last twenty years, life science companies started outsourcing large portions of their R&D activities to external suppliers, including complex, specialized services that were traditionally performed in-house. Outsourcing has become an integral part of life science R&D over the last two decades. There are several reasons for this shift. The cost of drug development […]

May 16, 2023 - 2 minutesmins - By Alexander Burik

Expert Advice 20 Mar 2023

Nine tips to succeed in pharma-biotech partnerships

The question of whether to partner with another company is critical to the long-term development of a biotech. Nonetheless, it can be easy for a small company to underestimate the resources it needs to put into a successful collaboration. Here, we’ll go over some expert advice on what to do and what not to do […]

March 20, 2023 - 9 minutesmins - By Alexander Burik

In Depth 3 Mar 2023

Let’s Take a Closer Look at 7 Autoimmune Diseases Biotechs are Fighting to Treat

While we mostly think of disease as being caused by bacteria or viruses, an illness can often occur when the body’s own defenses turn against itself. Here we’ll take a look at seven rare autoimmune diseases you may not have heard of and what biotechs are doing to treat them. The body’s immune system can […]

March 3, 2023 - 8 minutesmins - By Alexander Burik

Streamlining CAR-T cell therapy manufacturing: a platform approach

Chimeric antigen receptor-T cell (CAR-T) therapy is an exciting treatment modality for blood cancers that do not respond to standard treatment. But manufacturing these CAR-T therapies brings challenges. How can life science companies overcome them to minimize costs and improve patient access? In patients with cancer for whom chemotherapy proves unsuccessful, CAR-T therapy may provide […]

February 7, 2023 - 7 minutesmins - By Alexander Burik

Improving rare disease diagnosis and treatment with next generation sequencing technology

Rare diseases refer to over 7,000 different known health conditions that together affect up to over 350 million individuals worldwide. Diagnosing and treating rare diseases often proves to be difficult, since symptoms can be similar to those of common diseases, and treatment options are limited. However, next generation sequencing (NGS) technologies are making it easier […]

February 2, 2023 - 6 minutesmins - By Alexander Burik

cancer cell screening drug discovery microplate

Cancer cell line screening: a compass for drug discovery

Large-panel cancer cell line screening can help find the right fit between a specific cancer cell and a therapeutic molecule, leading to the development of effective treatments. How can robust quality control, real-time screening methods, and a set of unique screening panels address current screening challenges? Human cell lines have been used in drug development […]

January 24, 2023 - 5 minutesmins - By Alexander Burik

Navigating cell and gene therapy manufacturing with a long-term partnership

Cell and gene therapies have proven to be promising treatments for cancers and genetic diseases, but developers face key challenges before these treatments reach patients’ bedsides. A long-term partnership with a contract development and manufacturing organization (CDMO) can ease the path life science companies travel from manufacturing these life-changing treatments and bringing them to the […]

January 17, 2023 - 7 minutesmins - By Alexander Burik

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us